Literature DB >> 8738203

Outbreak of severe Pseudomonas aeruginosa respiratory infections due to contaminated nebulizers.

N A Cobben1, M Drent, M Jonkers, E F Wouters, M Vaneechoutte, E E Stobberingh.   

Abstract

During the six months from January-June 1994, 10 cases of severe and 11 of less severe pulmonary infection caused by Pseudomonas aeruginosa were diagnosed in patients with chronic obstructive airways disease. Possible sources were evaluated. P. aeruginosa was isolated from four of the 22 nebulizers tested. The relationship of isolates from the patients and nebulizers was confirmed by sero- and phage-typing, and by arbitrarily-primed polymerase chain reaction (AP-PCR). Three types were identified and the distribution of types in patients with severe infection was as follows (one patient had a multiple infection). Type I was isolated from two nebulizers and from sputa, and/or blood and/or bronchial protected specimen brush samples or bronchial lavage fluid from four patients. Type II came from the sputa of three patients and a third nebulizer; and type III from sputa and/or blood of four further patients and another nebulizer. The data provided evidence for the relation between P. aeruginosa as a cause of infection and the contamination of the nebulizers. When nebulizer mouthpieces were changed every 24 h and sterilized between patients, no more contamination occurred, and the outbreak ceased.

Entities:  

Mesh:

Year:  1996        PMID: 8738203     DOI: 10.1016/s0195-6701(96)90030-4

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  14 in total

Review 1.  Health service careers for people with cystic fibrosis.

Authors:  Sarah Walters
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

Review 2.  Aerosol therapy for obstructive lung diseases: device selection and practice management issues.

Authors:  Michael W Sims
Journal:  Chest       Date:  2011-09       Impact factor: 9.410

3.  Efficient management and maintenance of ultrasonic nebulizers to prevent microbial contamination.

Authors:  Yoko Ida; Hiroaki Ohnishi; Kouji Araki; Ryoichi Saito; Shin Kawai; Takashi Watanabe
Journal:  World J Methodol       Date:  2016-03-26

4.  Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance.

Authors:  V Dubois; C Arpin; M Melon; B Melon; C Andre; C Frigo; C Quentin
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

5.  Rapid and sensitive detection of Pseudomonas aeruginosa in chlorinated water and aerosols targeting gyrB gene using real-time PCR.

Authors:  C S Lee; K Wetzel; T Buckley; D Wozniak; J Lee
Journal:  J Appl Microbiol       Date:  2011-08-16       Impact factor: 3.772

6.  Analysis of acquisition of Pseudomonas aeruginosa gastrointestinal mucosal colonization and horizontal transmission in a murine model.

Authors:  Akinobu Kamei; Andrew Y Koh; Mihaela Gadjeva; Gregory P Priebe; Stephen Lory; Gerald B Pier
Journal:  J Infect Dis       Date:  2010-01-01       Impact factor: 5.226

7.  Noninvasive ventilation for patients near the end of life: what do we know and what do we need to know?

Authors:  William J Ehlenbach; J Randall Curtis
Journal:  Crit Care Med       Date:  2008-03       Impact factor: 7.598

Review 8.  Outbreaks of healthcare-associated infections linked to water-containing hospital equipment: a literature review.

Authors:  Wing-Kee Yiek; Olga Coenen; Mayke Nillesen; Jakko van Ingen; Edmée Bowles; Alma Tostmann
Journal:  Antimicrob Resist Infect Control       Date:  2021-05-10       Impact factor: 4.887

9.  Contaminated mouth swabs caused a multi-hospital outbreak of Pseudomonas aeruginosa infection.

Authors:  Bjørn G Iversen
Journal:  J Oral Microbiol       Date:  2010-04-20       Impact factor: 5.474

10.  Pseudomonas aeruginosa contamination of mouth swabs during production causing a major outbreak.

Authors:  Bjørn G Iversen; Hanne-Merete Eriksen; Gjermund Bø; Kristian Hagestad; Trond Jacobsen; Eva Engeset; Jørgen Lassen; Preben Aavitsland
Journal:  Ann Clin Microbiol Antimicrob       Date:  2007-03-13       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.